Ketryx raises $39M to help medical device makers ship safer products faster
Table of Contents
Ketryx Corp., a company transforming product lifecycle development and compliance for medical device makers with artificial intelligence, today announced it has raised $39 million in a Series B funding round led by Transformation Capital.
The round brings Ketryx’s total funding to more than $55 million, with participation from existing investors that include Lightspeed Venture Partners, MIT’s E14 Fund, Ubiquity Ventures and 53 Stations.
Founded in 2021 by Chief Executive Erez Kaminski, Ketryx is building an AI-native compliance platform designed to speed up product development while maintaining rigorous safety standards. Kaminski told SiliconANGLE in an interview he was inspired to launch the company after seeing how long and difficult it was for medical technology firms to bring innovations to market.
“Everything that’s meaningful is regulated,” Kaminski said. “I didn’t even comprehend how hard it could be.”
